PJ Online | News: New BCG vaccine
The Pharmaceutical Journal
New BCG vaccine
A new BCG (tuberculosis) vaccine (BCG vaccine SSI) has been launched this week by Danish company Staten Serum Institut (see p776). The launch follows the recall of all batches of BCG vaccine manufactured by Evans Vaccines (PJ, 5 October, p470).
The dose of BCG vaccine SSI for children aged 12 months and older is 0.1ml by intradermal injection, whereas the same dose of the Evans BCG vaccine was for children aged three months and older. Children under 12 months should be given 0.05ml of BCG vaccine SSI. A percutaneous preparation of BCG vaccine SSI for use by the multiple puncture technique has not been produced.
Citation: The Pharmaceutical Journal URI: 20008277
Recommended from Pharmaceutical Press
This new edition of Dale and Appelbe's Pharmacy and Medicines Law is the definitive guide to law and ethics for pharmacy practice in the UK. It covers law and professional regulation and is firmly established as the definitive student textbook and reference work on this subject in the UK. Fully updated to include changes to pharmacy laws and regulation.£57.00Buy now